TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Skin Elements Limited ( (AU:SKN) ) has shared an announcement.
Skin Elements Limited has secured $2.5 million through a two-tranche placement at $0.002 per share, with additional options, to fund the commercialization of its SE Formula biotechnology. This capital injection, managed by 62 Capital Pty Ltd, will support the company’s transition into commercial revenue programs, although it will result in a 64% dilution of current shareholders’ holdings.
More about Skin Elements Limited
Skin Elements Limited operates in the biotechnology industry, focusing on all-natural antimicrobial biotechnology. The company’s primary products include the SE Formula, Soleo Organics sunscreen, PapayaActivs therapeutic skincare, SuprCuvr disinfectant, and ECO-Nurture agriculture biostimulant, targeting personal protection and agricultural markets.
Current Market Cap: A$3.15M
For detailed information about SKN stock, go to TipRanks’ Stock Analysis page.